Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study

AIMS : Anticoagulation was associated with improved survival of hospitalized coronavirus disease 2019 (COVID-19) patients in large-scale studies. Yet, the development of COVID-19-associated coagulopathy (CAC) and the mechanism responsible for improved survival of anticoagulated patients with COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereyra, David, Heber, Stefan, Schrottmaier, Waltraud C, Santol, Jonas, Pirabe, Anita, Schmuckenschlager, Anna, Kammerer, Kerstin, Ammon, Daphni, Sorz, Thomas, Fritsch, Fabian, Hayden, Hubert, Pawelka, Erich, Krüger, Philipp, Rumpf, Benedikt, Traugott, Marianna T, Glaser, Pia, Firbas, Christa, Schörgenhofer, Christian, Seitz, Tamara, Karolyi, Mario, Pabinger, Ingrid, Brostjan, Christine, Starlinger, Patrick, Weiss, Günter, Bellmann-Weiler, Rosa, Salzer, Helmut J F, Jilma, Bernd, Zoufaly, Alexander, Assinger, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500043/
https://www.ncbi.nlm.nih.gov/pubmed/34609480
http://dx.doi.org/10.1093/cvr/cvab308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500043/
https://www.ncbi.nlm.nih.gov/pubmed/34609480
http://dx.doi.org/10.1093/cvr/cvab308

Ejemplares similares